From Porcine to Synthetic: Overcoming Translational Hurdles in Exosome-Mediated Ocular Drug Delivery

This research presents a new method for delivering life-saving medication to the back of the human eye without the use of painful and risky needles . While recent breakthroughs have used animal-derived particles to bypass the eye's natural barriers, this paper proposes a fully synthetic, laboratory-made alternative: Functionalized Solid Lipid Nanoparticles (SLNs). By mimicking a natural "lockpick" mechanism found in biology, this system can safely and temporarily open the eye's protective junctions to target childhood eye cancer (retinoblastoma) with high precision . This synthetic transition solves the major issues of immune rejection and mass production, paving the way for painless eye drops to treat chronic and deep ocular diseases